BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.

Andere talen Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Aandelen

688621

CNE100005139

slotkoers Shanghai S.E. Andere beurzen 00:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
42,7 ^CNY	-1,29%		-9,63%	-38,78%

25/04	Beijing Sun-Novo Pharmaceutical Research Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
26/02	Beijing Sun-Novo Pharmaceutical Research Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(XSSC:688621) added to S&P Global BMI Index	18-09-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	04-09-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28-08-23
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	16-05-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28-04-23
Sun-Novo Pharma Unit Gets Drug Regulator's Certification for Desmopressin Injection	13-04-23
Sun-Novo Pharma Unit to Set Up 10 Million Joint Venture With Midea Pharma	12-04-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	11-04-23
Sun-Novo Pharma Logs 49.8% Jump in 2022 Profit	10-02-23
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	09-02-23
Sun-Novo Pharmaceutical Purchases Azilsartan Tablets’ Marketing Rights For $5 Million	23-11-22
Beijing Sun-Novo Gets Regulatory Approval in China For Anti-Dermatitis Cream	22-11-22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	07-11-22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. agreed to acquire Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership), Liu Yujing and other shareholders.	25-10-22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24-10-22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	09-08-22
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(SHSE:688621) added to Shanghai Stock Exchange Composite Index	21-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Aandelen

688621

CNE100005139

Andere talen

Filters